Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-07

Clinical Trial Update: Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Kudzu extract for reducing alcohol consumption in treatment-seeking individuals with alcohol use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kudzu extract (Pueraria lobata extract)

Snippet

Sponsor: Mclean Hospital | Conditions: Alcohol Abuse, Alcohol Dependence | Phase 2 | Status: WITHDRAWN